抗肿瘤治疗所致心脏疾病的研究进展
孟超， 梁军 - 肿瘤防治研究, 2018 - zlfzyj.com
… adverse effects of anticancer therapies have increased significantly, especially the treatment
of cardiovascular toxicity … A systematic overview of radiation therapy effects in breast cancer[…
of cardiovascular toxicity … A systematic overview of radiation therapy effects in breast cancer[…
探索天然产物缓解阿尔茨海默病的功效
… The research on natural products have gained importance as the active compounds extracted
from them have medicinal values with reduced side effects, and they are bioavailable. The …
from them have medicinal values with reduced side effects, and they are bioavailable. The …
[PDF][PDF] PD-1/PD-L1 单抗药物抗肿瘤免疫治疗相关不良反应及超进展疾病研究进展
王鹏焱， 林子又， 朱凯， 张小雷 - 中国药理学与毒理学杂志, 2024 - cjpt.magtechjournal.com
… Long-term clini⁃ cal outcomes and biomarker analyses of atezoli⁃ zumab therapy for patients
with metastatic triplenegative breast cancer: a phase 1 study[J]. JAMA Oncol, 2019, 5(1): …
with metastatic triplenegative breast cancer: a phase 1 study[J]. JAMA Oncol, 2019, 5(1): …
肝移植临床免疫抑制剂及新药研究进展.
陈泉余， 蒋师放， 夏仁培， 帅领… - … /Qi Guan Yi Zhi, 2020 - search.ebscohost.com
… mTOR 抑制剂主要包 括西罗莫司(sirolimus, SRL)和依维莫司(everolimus). SRL 是20 世纪70
… toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer …
… toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer …
[PDF][PDF] 3D 打印个性化药物用于儿科制剂的前景······· 韩晓璐, 王增明, 高静, 张慧, 郑爱萍
XL HAN, ZM WANG, J GAO, H ZHANG, AP ZHENG - cjph.com.cn
… of total patient population with breast cancer. As a mortal subtype of breast cancer, TNBC
is … the combination of carboplatin and everolimus for the treatment of advanced triple-negative …
is … the combination of carboplatin and everolimus for the treatment of advanced triple-negative …
IS-S1-1 指_ H Autoimmune hepatitis in
A Takahashi, H Ohira - jstage.jst.go.jp
… toxicities were observed in 70, 70, and 19% of the patients with treated with FFX, GnP, and
GEM, respectively. The reasons for treatment … Everolimus is the first targeted agent to show …
GEM, respectively. The reasons for treatment … Everolimus is the first targeted agent to show …
[HTML][HTML] 抗肿瘤抗生素药物制剂的研究进展
刘薇， 陈丽青， 辛欣， 黄伟， 高钟镐 - 药学学报, 2018 - html.rhhz.net
… However, there are always various problems associated with anti-tumor antibiotics, such as
poor solubility and instability as well as severe systemic side effects. It is important to choose …
poor solubility and instability as well as severe systemic side effects. It is important to choose …